Recent developments in the classification and assessment of vasculitis

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 3, 2009, Pages 429-443

  Watts, Richard A ^a   Scott, David G I ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

assessment; classification criteria; damage index; diagnostic criteria; disease activity; vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; STEROID;

ALGORITHM; ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DRUG MEGADOSE; GIANT CELL ARTERITIS; HUMAN; LOW DRUG DOSE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; STANDARDIZATION; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

ALGORITHMS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; EARLY DIAGNOSIS; HUMANS; VASCULITIS;

EID: 66349114572     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.12.004     Document Type: Review

References (46)

1. Kussmaul A.M.K. Uber eine nicht bisher beschriebene eigenthumliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskelahmung einhergeht. Deutsche Archiv Klinische Medizin 1 (1866) 484-518
2. Matteson E.L. A history of early investigation in polyarteritis nodosa. Arthritis Care Res 12 4 (1999) 294-302
3. Zeek P.M. Periarteritis nodosa; a critical review. Am J Clin Pathol 22 8 (1952) 777-790
4. Davson J.B.J., and Platt R. The kidney in periarteritis nodosa. Q J Med 17 (1948) 175-202
5. Fries J.F., Hunder G.G., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33 8 (1990) 1135-1136
6. Arend W.P., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33 8 (1990) 1129-1134
7. Bloch D.A., Michel B.A., Hunder G.G., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 33 8 (1990) 1068-1073
8. Calabrese L.H., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33 8 (1990) 1108-1113
9. Hunder G.G., Arend W.P., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33 8 (1990) 1065-1067
10. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 8 (1990) 1122-1128
11. Leavitt R.Y., Fauci A.S., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33 8 (1990) 1101-1107
12. Lightfoot Jr. R.W., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33 8 (1990) 1088-1093
13. Masi A.T., Hunder G.G., Lie J.T., et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33 8 (1990) 1094-1100
14. Mills J.A., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33 8 (1990) 1114-1121
15. Rao J.K., Allen N.B., and Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 129 5 (1998) 345-352
16. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 2 (1994) 187-192
17. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA assay standardization. Kidney Int 53 3 (1998) 743-753
18. Sorensen S.F., Slot O., Tvede N., and Petersen J. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 59 6 (2000) 478-482
19. Jayne D., Rasmussen N., Andrassy K., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349 1 (2003) 36-44
20. Lane S.E., Watts R.A., Barker T.H., and Scott D.G. Evaluation of the Sorensen diagnostic criteria in the classification of systemic vasculitis. Rheumatology (Oxford) 41 10 (2002) 1138-1141
21. Reid A.J., Harrison B.D., Watts R.A., et al. Churg-Strauss syndrome in a district hospital. QJM 91 3 (1998) 219-229
22. Lanham J.G., Elkon K.B., Pusey C.D., and Hughes G.R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63 2 (1984) 65-81
23. Lane S.E., Watts R.A., Shepstone L., and Scott D.G. Primary systemic vasculitis: clinical features and mortality. Qjm 98 2 (2005) 97-111
24. Watts R., Lane S., Hanslik T., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66 (2007) 222-227
25. Guillevin L., Pagnoux C., and Teixera L. Polyarteritis Nodosa. Vasculitis. 2nd edn. In: Bridges L., and Ball G. (Eds) (2008), Oxford University Press, Oxford 335-353
26. Liu L.J., Chen M., Yu F., et al. Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 47 5 (2008) 708-712
27. Watts R.A., Scott D.G., Jayne D.R., et al. Renal vasculitis in Japan and the UK - are there differences in epidemiology and clinical phenotype?. Nephrol Dial Transplant 23 12 (2008) 3928-3931
28. Henegar C., Pagnoux C., Puechal X., et al. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 58 5 (2008) 1528-1538
29. Ozen S., Ruperto N., Dillon M.J., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65 7 (2006) 936-941
30. Committee JKDR. Diagnostic Guidelines for Kawasaki Disease. 2002 5th edn. Tokyo.
31. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114 6 (2004) 1708-1733
32. Ozen S., Anton J., Arisoy N., et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145 4 (2004) 517-522
33. Luqmani R.A., Bacon P.A., Moots R.J., et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87 11 (1994) 671-678
34. Luqmani R.A., Exley A.R., Kitas G.D., and Bacon P.A. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 11 2 (1997) 423-446
35. Flossmann O., Bacon P., de Groot K., et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 66 3 (2007) 283-292
36. de Groot K., Gross W.L., Herlyn K., and Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 55 1 (2001) 31-38
37. Stone J.H., Hoffman G.S., Merkel P.A., et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44 4 (2001) 912-920
38. Mahr A.D., Neogi T., Lavalley M.P., et al. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum 59 6 (2008) 884-891
39. Merkel P.A., Seo P., Aries P., et al. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol 32 12 (2005) 2488-2495
40. Guillevin L., Lhote F., Gayraud M., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75 1 (1996) 17-28
41. Misra R.D., Jayaseelan D., Sivakumar L., et al. ITAS and DEI.TAK - Scores for clinical disease activity and damage extent in Takayasu aorto-arteritis. Rheumatology (Oxford) 47 (2008) ii101
42. Exley A.R., Bacon P.A., Luqmani R.A., et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40 2 (1997) 371-380
43. Exley A.R., Carruthers D.M., Luqmani R.A., et al. Damage occurs early in systemic vasculitis and is an index of outcome. QJM 90 6 (1997) 391-399
44. Seo P., Luqmani R.A., Flossmann O., et al. The future of damage assessment in vasculitis. J Rheumatol 34 6 (2007) 1357-1371
45. Koutantji M., Harrold E., Lane S.E., et al. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49 6 (2003) 826-837
46. Nataraja A., Mukhtyar C., Helmich B., et al. Outpatient assessment of systemic vasculitis. Best Pract Res Clin Rheumatol 21 (2007) 713-732